Related Experiment Video
Updated: Dec 29, 2025

07:13
An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
Published on: December 7, 2016
13.8K
State and Trait Anxiety Scores of Patients Receiving Intravitreal Injections.
Ozcan Kayikcioglu1, Sinan Bilgin2, Goktug Seymenoglu1
1Department of Ophthalmology, Celal Bayar University, Manisa, Turkey.
Biomedicine Hub
|January 29, 2020
Summary
Intravitreal injections did not significantly alter state or trait anxiety based on patient experience or sociodemographic factors. Healthcare providers should focus on reducing patient anxiety during treatment.
Area of Science:
- Ophthalmology
- Psychology
Background:
- Intravitreal injections are a common treatment for various ocular conditions.
- Patient anxiety is a significant factor influencing treatment adherence and outcomes.
Purpose of the Study:
- To assess state and trait anxiety levels in patients undergoing intravitreal injections.
- To determine if patient experience or sociodemographic factors influence anxiety scores.
Main Methods:
- A study included 113 patients receiving intravitreal ranibizumab or bevacizumab.
- Spielberg's State-Trait Anxiety Inventory questionnaire was used to measure anxiety.
- Anxiety scores were compared between experienced and inexperienced patients, and across sociodemographic groups.
Main Results:
- No statistically significant differences in state or trait anxiety scores were found between experienced and inexperienced patients.
- Anxiety scores did not significantly differ between male and female, employed, and retired patients.
- All patient groups exhibited high anxiety scores, indicating a need for intervention.
Conclusions:
- Sociodemographic status does not appear to significantly impact anxiety levels in patients receiving intravitreal injections.
- High anxiety levels observed underscore the importance of anxiety management strategies in ophthalmic treatments.
- Healthcare providers should proactively address and mitigate patient anxiety during the intravitreal injection treatment course.
Related Concept Videos
Generalized Anxiety Disorder
573
Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...
573
Anxiety: Overview
790
Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.
790

